Core Viewpoint - Hu Ye, a prominent biomedical scientist, has returned to China after 22 years in the U.S., criticizing the Trump administration's funding cuts to the NIH, which totaled $8.3 million, impacting critical research areas [1][3]. Group 1: Background and Career - Hu Ye served as a professor at Tulane University and has a strong academic background, having graduated from Lanzhou University and Tsinghua University, and obtained advanced degrees from the University of Texas [6][7]. - He has held various prestigious positions, including founding director of the Intelligent Molecular Diagnostics Center and has been involved in significant research projects funded by institutions like the NIH and the Gates Foundation [7][8]. Group 2: Research Impact and Funding Cuts - Hu Ye publicly warned that the proposed federal budget could reduce NIH's indirect cost reimbursement rate from 53% to 15%, which would severely affect scientific research [3]. - Specific NIH funding cuts include $3.7 million for early detection of tuberculosis and HIV in children, $3.1 million for blood-based cancer detection technology, and $1.5 million for advanced equipment procurement [3]. Group 3: Contributions to Biomedical Research - Hu Ye has focused on rapid virus detection and has published extensively in top journals, holding over 30 patents in nanomedicine [3][6]. - His laboratory developed a rapid COVID-19 testing kit that uses saliva and provides results in 15 minutes, showcasing his innovative contributions to public health [6][7]. Group 4: Future Directions at Tsinghua University - Upon returning to China, Hu Ye has taken on the role of Dean at Tsinghua University's School of Biomedical Engineering, aiming to advance research in infectious diseases, neurological disorders, and cancer diagnostics [7][8]. - His leadership is expected to enhance Tsinghua's position in the international biomedical field, as noted by the university's vice president [8].